Pharmaceutical Division
Atovaquone
Atovaquone is an antiprotozoal medication used to treat and prevent Pneumocystis pneumonia.
Anti-protozoalCAS 95233-18-4
Quality Assured
Antiprotozoal
Bulk Supply
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Atovaquone – CAS 95233-18-4
CAS Number
95233-18-4
Category
Anti-protozoal
Therapeutic Class
Antiprotozoal
Description
Atovaquone is an antiprotozoal medication used to treat and prevent Pneumocystis pneumonia.
Applications
- Pneumocystis pneumonia
- Malaria prevention
- Toxoplasmosis
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.